124 related articles for article (PubMed ID: 37247892)
1. Safety of Carbon-ion Radiotherapy for Prostate Cancer After Rectal Cancer Surgery.
Takakusagi Y; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Kamada T; Katoh H
Anticancer Res; 2023 Jun; 43(6):2691-2695. PubMed ID: 37247892
[TBL] [Abstract][Full Text] [Related]
2. Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer.
Takakusagi Y; Katoh H; Kano K; Anno W; Tsuchida K; Mizoguchi N; Serizawa I; Yoshida D; Kamada T
Radiat Oncol; 2020 May; 15(1):127. PubMed ID: 32460889
[TBL] [Abstract][Full Text] [Related]
3. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
[TBL] [Abstract][Full Text] [Related]
4. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect.
Lee WR; Hanks GE; Hanlon AL; Schultheiss TE; Hunt MA
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):251-7. PubMed ID: 8635930
[TBL] [Abstract][Full Text] [Related]
5. The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience.
Cai X; Du Y; Wang Z; Li P; Yu Z; Zhang Q; Zhang Z
Radiat Oncol; 2020 Aug; 15(1):209. PubMed ID: 32859234
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
[TBL] [Abstract][Full Text] [Related]
7. Carbon ion radiotherapy for prostate cancer with bladder invasion.
Miyasaka Y; Kawamura H; Sato H; Kubo N; Mizukami T; Matsui H; Miyazawa Y; Ito K; Nakano T; Suzuki K; Ohno T
BMC Urol; 2021 Aug; 21(1):106. PubMed ID: 34362355
[TBL] [Abstract][Full Text] [Related]
8. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiation therapy for prostate cancer after rectal surgery: a single hospital long-term safety analysis.
Zhang S; Nakamura K; Aizawa R; Akamatsu S; Mizowaki T
Int J Clin Oncol; 2022 May; 27(5):977-982. PubMed ID: 35122170
[TBL] [Abstract][Full Text] [Related]
10. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
[TBL] [Abstract][Full Text] [Related]
11. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
[TBL] [Abstract][Full Text] [Related]
12. Five-year clinical outcomes of scanning carbon-ion radiotherapy for prostate cancer.
Takakusagi Y; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Kamada T; Katoh H
PLoS One; 2024; 19(3):e0290617. PubMed ID: 38457424
[TBL] [Abstract][Full Text] [Related]
13. Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experience.
Fonteyne V; Sadeghi S; Ost P; Vanpachtenbeke F; Vuye P; Lumen N; De Meerleer G
Acta Oncol; 2015 Jun; 54(6):854-61. PubMed ID: 25387271
[TBL] [Abstract][Full Text] [Related]
14. Polyethylene glycol hydrogel rectal spacer implantation in patients with prostate cancer undergoing combination high-dose-rate brachytherapy and external beam radiotherapy.
Yeh J; Lehrich B; Tran C; Mesa A; Baghdassarian R; Yoshida J; Torrey R; Gazzaniga M; Weinberg A; Chalfin S; Ravera J; Tokita K
Brachytherapy; 2016; 15(3):283-287. PubMed ID: 26853354
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks.
Nomiya T; Tsuji H; Maruyama K; Toyama S; Suzuki H; Akakura K; Shimazaki J; Nemoto K; Kamada T; Tsujii H;
Br J Cancer; 2014 May; 110(10):2389-95. PubMed ID: 24722181
[TBL] [Abstract][Full Text] [Related]
16. Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?
Kupelian PA; Reddy CA; Carlson TP; Willoughby TR
Cancer J; 2002; 8(1):62-6. PubMed ID: 11895204
[TBL] [Abstract][Full Text] [Related]
17. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
[TBL] [Abstract][Full Text] [Related]
18. Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer.
Bohrer M; Schröder P; Welzel G; Wertz H; Lohr F; Wenz F; Mai SK
Strahlenther Onkol; 2008 Dec; 184(12):674-8. PubMed ID: 19107349
[TBL] [Abstract][Full Text] [Related]
19. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer.
van der Laan HP; van den Bergh A; Schilstra C; Vlasman R; Meertens H; Langendijk JA
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1138-45. PubMed ID: 17931794
[TBL] [Abstract][Full Text] [Related]
20. Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales.
Hanlon AL; Schultheiss TE; Hunt MA; Movsas B; Peter RS; Hanks GE
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):59-63. PubMed ID: 9212005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]